# A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.

> **NCT02135887** · — · UNKNOWN · sponsor: **Microbio Co Ltd** · enrollment: 184 (estimated)

## Conditions studied

- Stage III Colorectal Cancer
- Neutropenia

## Interventions

- **DRUG:** MB-6
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02135887
- **Lead sponsor:** Microbio Co Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11-04
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2020-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02135887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02135887, "A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02135887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*